Madrigal Pharmaceuticals (MDGL) Stock Insights

MDGL price $431.00 -9.33 -2.12%

Ticker
MDGL
Price
$431.00
Change
-9.33 -2.12%
Market cap ?
$9.96B
P/E ?
-33.96
Forward P/E ?
75.87
Dividend yield ?
0.00%
Beta ?
-1.05
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
64
Value
48
Quality
44
Growth
100

Stocklytics score rationale: value 48, quality 44, growth 100.

Financials

2016201720182019202020212022202320242025
00000000180133000958403000

Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development phase, concentrating its efforts on discovering and commercializing innovative treatments for cardiovascular, metabolic, and liver disorders. Its most advanced drug candidate, resmetirom, functions as a liver-targeted selective thyroid hormone receptor-ß agonist, currently undergoing late-stage (Phase III) clinical trials for…

Fair value

MDGL fair value $309.78. Price $431.00. Price is 39% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 250.96M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.00%. Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 23.10M. Net debt 155.67M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare MDGL

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-03—-0.86—404.17M
2026-07-30-1.99-2.68364.30M352.13M
2026-05-06-3.25-3.61311.34M301.05M
2026-02-19-2.570.04321.10M312.51M
2025-11-04-5.08-2.04287.27M244.96M
2025-08-05-1.90-3.48212.80M243.47M
2025-05-01-3.32-3.62137.25M158.93M
2025-02-26-2.71-4.32103.32M97.81M
2024-10-31-4.92-6.9462.17M92.53M
2024-08-07-7.10-7.5514.64M3.90M
2024-05-07-7.38-6.06—3.90M
2024-02-28-5.68-5.32770.00K—
2023-11-06-5.34-4.78——
2023-08-08-4.69-4.47——
2023-05-09-4.23-4.98——
2023-02-23-4.98-4.41——
2022-11-03-4.75-4.05——
2022-08-04-4.14-3.76——
2022-05-09-3.36-3.75——
2022-02-24-3.78-3.92——
2021-11-04-3.79-3.89——
2021-08-05-3.72-3.55——
2021-05-06-3.32-3.78——
2021-02-25-3.82-3.82——
2020-11-05-3.75-3.35—4.83M
2020-08-06-3.18-2.42—4.34M
2020-05-07-2.34-1.94——
2020-02-26-1.80-1.56—4.62M
2019-11-06-1.39-1.36—5.19M
2019-08-07-1.28-1.08—6.67M
2019-05-08-0.98-0.93—5.69M
2019-02-27-0.75-0.75——
2018-11-06-0.56-0.54——
2018-08-07-0.45-0.56——
2018-05-08-0.45-0.75——
2018-03-13-0.67-0.68——
2017-11-09-0.68-0.84——
2017-08-10-0.69-0.60—1.41M
2017-05-11-0.50-1.39——
2017-04-03-0.67———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-11Sibold William JohnSell60$533.0931.99K
2026-09-11Sibold William JohnSell106$534.0656.61K
2026-09-11Sibold William JohnSell218$535.94116.84K
2026-09-11Sibold William JohnSell160$537.6286.02K
2026-09-11Sibold William JohnSell687$540.59371.38K
2026-09-11Sibold William JohnSell368$541.64199.32K
2026-09-11Sibold William JohnSell1.20K$542.60652.21K
2026-09-11Sibold William JohnSell1.54K$544.02837.25K
2026-09-11Sibold William JohnSell761$544.83414.62K
2026-09-11Sibold William JohnSell120$546.3865.57K
2026-09-09Sibold William JohnSell131$527.8869.15K
2026-09-09Sibold William JohnSell347$529.27183.66K
2026-09-09Sibold William JohnSell522$530.23276.78K
2026-09-09Sibold William JohnSell368$531.99195.77K
2026-09-09Sibold William JohnSell512$533.09272.94K
2026-09-09Sibold William JohnSell396$534.20211.54K
2026-09-09Sibold William JohnSell644$535.27344.72K
2026-09-09Sibold William JohnSell1.04K$536.11557.56K
2026-09-09Sibold William JohnSell640$537.17343.79K
2026-09-09Sibold William JohnSell520$538.30279.91K
2026-09-09Sibold William JohnSell215$539.03115.89K
2026-09-09Sibold William JohnSell505$540.19272.80K
2026-09-09Sibold William JohnSell362$541.65196.08K
2026-09-09Sibold William JohnSell160$542.5586.81K
2026-08-17Kelley Shannon TSell664$514.97341.94K
2026-08-15REED JOHN CBuy1.08K$507.56547.15K
2026-08-15REED JOHN CBuy647——
2026-08-11REED JOHN COther0——
2026-07-20Sibold William JohnSell140$542.7575.98K
2026-07-20Sibold William JohnSell110$543.7959.82K
2026-07-20Sibold William JohnSell545$544.71296.87K
2026-07-20Sibold William JohnSell275$545.71150.07K
2026-07-20Sibold William JohnSell269$547.08147.16K
2026-07-20Sibold William JohnSell680$547.70372.43K
2026-07-20Sibold William JohnSell47$548.8725.80K
2026-07-20Sibold William JohnSell153$550.0184.15K
2026-07-20Sibold William JohnSell1$550.72551
2026-07-20Sibold William JohnSell280$555.05155.41K
2026-07-17Sibold William JohnBuy50.00K——
2026-07-17Sibold William JohnSell50.00K——
2026-06-17Taub RebeccaBuy454——
2026-06-17Taub RebeccaBuy766$499.86382.89K
2026-06-17Levy Richard SBuy454——
2026-06-17Levy Richard SBuy766$499.86382.89K
2026-06-17FOUSE JACQUALYN ABuy454——
2026-06-17FOUSE JACQUALYN ABuy766$499.86382.89K
2026-06-17Daly James MBuy454——
2026-06-17Daly James MBuy766$499.86382.89K
2026-06-17Brennan Daniel J.Buy404——
2026-06-17Brennan Daniel J.Buy681$499.86340.40K
2026-06-17BAKER BROS. ADVISORS LPBuy908——
2026-06-17BAKER BROS. ADVISORS LPBuy908——
2026-06-17BAKER BROS. ADVISORS LPBuy1.53K$499.86765.79K
2026-06-01Soergel DavidSell1.04K$495.74516.56K
2026-05-22Levy Richard SSell40$506.6820.27K
2026-05-22Levy Richard SSell320$508.24162.64K
2026-05-22Levy Richard SSell151$510.3677.06K
2026-05-22Levy Richard SSell610$511.40311.95K
2026-05-22Levy Richard SSell439$512.50224.99K
2026-05-22Levy Richard SSell40$512.9720.52K
2026-05-22Levy Richard SSell343$514.67176.53K
2026-05-22Levy Richard SSell657$515.92338.96K
2026-05-22Levy Richard SSell723$516.87373.69K
2026-05-22Levy Richard SSell1.50K$517.59774.84K
2026-05-22Levy Richard SSell782$518.76405.67K
2026-05-22Levy Richard SSell80$519.9841.60K
2026-05-18Soergel DavidSell844$515.90435.42K
2026-03-06Dier MardiSell646$431.94279.03K
2026-03-06Dier MardiSell40$425.0817.00K
2026-03-06Dier MardiSell420$426.86179.28K
2026-03-06Dier MardiSell80$427.8534.23K
2026-03-06Dier MardiSell160$429.0068.64K
2026-03-06Dier MardiSell40$429.5817.18K
2026-03-06Dier MardiSell120$430.9051.71K
2026-03-06Dier MardiSell116$432.5650.18K
2026-03-06Dier MardiSell160$434.2069.47K
2026-03-06Dier MardiSell80$435.3134.83K
2026-03-06Dier MardiSell80$436.6934.94K
2026-03-06Dier MardiSell40$437.6517.51K
2026-03-06Sibold William JohnSell1.66K$431.94718.32K
2026-03-06Kelley Shannon TSell360$431.94155.50K
2026-03-06Huntsman CaroleSell419$431.94180.98K
2026-03-06Taub RebeccaSell491$431.94212.08K
2026-03-04Dier MardiBuy5.21K——
2026-03-04Dier MardiBuy6.52K$434.802.83M
2026-03-04Sibold William JohnBuy14.99K——
2026-03-04Sibold William JohnBuy18.74K$434.808.15M
2026-03-04Kelley Shannon TBuy4.02K——
2026-03-04Kelley Shannon TBuy5.02K$434.802.18M
2026-03-04Huntsman CaroleBuy3.99K——
2026-03-04Huntsman CaroleBuy4.99K$434.802.17M
2026-03-04Soergel DavidBuy4.37K——
2026-03-04Soergel DavidBuy5.47K$434.802.38M
2026-03-02Dier MardiSell1.18K$427.21505.39K
2026-02-23Levy Richard SBuy2.50K$7.3618.40K
2026-02-23Levy Richard SSell2.50K$7.3618.40K
2026-01-26Levy Richard SBuy4.00K$16.4665.84K
2026-01-26Levy Richard SSell4.00K$16.4665.84K
2026-01-26Huntsman CaroleSell340$492.42167.42K
2026-01-26Huntsman CaroleSell570$494.59281.92K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 439, holders +31 vs prior quarter. Ownership 81.57%.

HolderSharesChangeChange %Value
BAKER BROS. ADVISORS LP2.14M1.43K+0.07%1.15B
RTW INVESTMENTS, LP1.99M00.00%1.07B
JUPITER TOPCO LLC1.94M1.94MNew1.04B
AVORO CAPITAL ADVISORS LLC1.83M15.15K+0.83%984.41M
PAULSON & CO. INC.1.34M-52.17K-3.75%719.52M
BLACKROCK, INC.1.20M-359.19K-23.03%644.75M
VANGUARD CAPITAL MANAGEMENT LLC835.67K8.52K+1.03%448.71M
WELLINGTON MANAGEMENT GROUP LLP825.71K130.76K+18.81%443.37M
VANGUARD PORTFOLIO MANAGEMENT LLC781.73K-59.41K-7.06%419.75M
STATE STREET CORP527.06K-82.47K-13.53%283.00M
CITADEL ADVISORS LLC507.23K470.93K+1297.34%272.36M
UBS GROUP AG401.71K283.93K+241.07%215.70M
GEODE CAPITAL MANAGEMENT, LLC374.88K-80.99K-17.77%201.34M
FMR LLC356.20K-155.53K-30.39%191.26M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC324.12K-16.40K-4.82%174.04M
INVESCO LTD.301.44K-28.08K-8.52%161.86M
ARMISTICE CAPITAL, LLC288.00K23.42K+8.85%154.64M
LORD, ABBETT & CO. LLC281.50K38.77K+15.97%151.15M
GOLDMAN SACHS GROUP INC246.28K-31.09K-11.21%132.24M
POLAR CAPITAL HOLDINGS PLC244.27K-45.04K-15.57%131.16M
AMERIPRISE FINANCIAL INC231.21K133.02K+135.49%124.15M
NORGES BANK213.89K213.89KNew114.85M
ARTISAN PARTNERS LIMITED PARTNERSHIP210.21K26.66K+14.53%112.87M
SUSQUEHANNA INTERNATIONAL GROUP, LLP209.80K187.58K+844.36%112.65M
PICTET ASSET MANAGEMENT HOLDING SA192.90K5.66K+3.02%103.49M

Insights

Revenue by product
PeriodValue
FY2025Reportable Segment: 958403000.0

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Madrigal Pharmaceuticals (MDGL) Stock Insights

MDGL$431.00-9.33 -2.12%

$9.96B

Market Cap

-33.96

P/E

75.87

Forward P/E

64

Score

Price History